CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Move strengthens footprint in Western India and expands multi-specialty care network
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
Subscribe To Our Newsletter & Stay Updated
